Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2001 Nov-Dec;7(6):927–932. doi: 10.3201/eid0706.010603

Trichomonas vaginalis, HIV, and African-Americans.

F Sorvillo 1, L Smith 1, P Kerndt 1, L Ash 1
PMCID: PMC2631893  PMID: 11747718

Abstract

Trichomonas vaginalis may be emerging as one of the most important cofactors in amplifying HIV transmission, particularly in African-American communities of the United States. In a person co-infected with HIV, the pathology induced by T. vaginalis infection can increase HIV shedding. Trichomonas infection may also act to expand the portal of entry for HIV in an HIV-negative person. Studies from Africa have suggested that T. vaginalis infection may increase the rate of HIV transmission by approximately twofold. Available data indicate that T. vaginalis is highly prevalent among African-Americans in major urban centers of the United States and is often the most common sexually transmitted infection in black women. Even if T. vaginalis increases the risk of HIV transmission by a small amount, this could translate into an important amplifying effect since Trichomonas is so common. Substantial HIV transmission may be attributable to T. vaginalis in African-American communities of the United States.

Full Text

The Full Text of this article is available as a PDF (46.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aral S. O., Mosher W. D., Cates W., Jr Vaginal douching among women of reproductive age in the United States: 1988. Am J Public Health. 1992 Feb;82(2):210–214. doi: 10.2105/ajph.82.2.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Barbone F., Austin H., Louv W. C., Alexander W. J. A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol. 1990 Aug;163(2):510–514. doi: 10.1016/0002-9378(90)91186-g. [DOI] [PubMed] [Google Scholar]
  3. Bell T. A., Farrow J. A., Stamm W. E., Critchlow C. W., Holmes K. K. Sexually transmitted diseases in females in a juvenile detention center. Sex Transm Dis. 1985 Jul-Sep;12(3):140–144. doi: 10.1097/00007435-198507000-00009. [DOI] [PubMed] [Google Scholar]
  4. Bersoff-Matcha S. J., Horgan M. M., Fraser V. J., Mundy L. M., Stoner B. P. Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. J Infect Dis. 1998 Oct;178(4):1174–1177. doi: 10.1086/515678. [DOI] [PubMed] [Google Scholar]
  5. Borchardt K. A., al-Haraci S., Maida N. Prevalence of Trichomonas vaginalis in a male sexually transmitted disease clinic population by interview, wet mount microscopy, and the InPouch TV test. Genitourin Med. 1995 Dec;71(6):405–406. doi: 10.1136/sti.71.6.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bunnell R. E., Dahlberg L., Rolfs R., Ransom R., Gershman K., Farshy C., Newhall W. J., Schmid S., Stone K., St Louis M. High prevalence and incidence of sexually transmitted diseases in urban adolescent females despite moderate risk behaviors. J Infect Dis. 1999 Nov;180(5):1624–1631. doi: 10.1086/315080. [DOI] [PubMed] [Google Scholar]
  7. Cates W., Jr Estimates of the incidence and prevalence of sexually transmitted diseases in the United States. American Social Health Association Panel. Sex Transm Dis. 1999 Apr;26(4 Suppl):S2–S7. doi: 10.1097/00007435-199904001-00002. [DOI] [PubMed] [Google Scholar]
  8. Cotch M. F., Pastorek J. G., 2nd, Nugent R. P., Hillier S. L., Gibbs R. S., Martin D. H., Eschenbach D. A., Edelman R., Carey J. C., Regan J. A. Trichomonas vaginalis associated with low birth weight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex Transm Dis. 1997 Jul;24(6):353–360. doi: 10.1097/00007435-199707000-00008. [DOI] [PubMed] [Google Scholar]
  9. Cotch M. F., Pastorek J. G., 2nd, Nugent R. P., Yerg D. E., Martin D. H., Eschenbach D. A. Demographic and behavioral predictors of Trichomonas vaginalis infection among pregnant women. The Vaginal Infections and Prematurity Study Group. Obstet Gynecol. 1991 Dec;78(6):1087–1092. [PubMed] [Google Scholar]
  10. Cu-Uvin S., Hogan J. W., Warren D., Klein R. S., Peipert J., Schuman P., Holmberg S., Anderson J., Schoenbaum E., Vlahov D. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis. 1999 Nov;29(5):1145–1150. doi: 10.1086/313434. [DOI] [PubMed] [Google Scholar]
  11. DeHovitz J. A., Kelly P., Feldman J., Sierra M. F., Clarke L., Bromberg J., Wan J. Y., Vermund S. H., Landesman S. Sexually transmitted diseases, sexual behavior, and cocaine use in inner-city women. Am J Epidemiol. 1994 Dec 15;140(12):1125–1134. doi: 10.1093/oxfordjournals.aje.a117212. [DOI] [PubMed] [Google Scholar]
  12. Draper D., Donohoe W., Mortimer L., Heine R. P. Cysteine proteases of Trichomonas vaginalis degrade secretory leukocyte protease inhibitor. J Infect Dis. 1998 Sep;178(3):815–819. doi: 10.1086/515366. [DOI] [PubMed] [Google Scholar]
  13. Fleisher J. M., Senie R. T., Minkoff H., Jaccard J. Condom use relative to knowledge of sexually transmitted disease prevention, method of birth control, and past or present infection. J Community Health. 1994 Dec;19(6):395–407. doi: 10.1007/BF02260322. [DOI] [PubMed] [Google Scholar]
  14. Fouts A. C., Kraus S. J. Trichomonas vaginalis: reevaluation of its clinical presentation and laboratory diagnosis. J Infect Dis. 1980 Feb;141(2):137–143. doi: 10.1093/infdis/141.2.137. [DOI] [PubMed] [Google Scholar]
  15. Ghys P. D., Diallo M. O., Ettiègne-Traoré V., Yeboué K. M., Gnaoré E., Lorougnon F., Kalé K., Van Dyck E., Brettegaard K., Hoyi Y. M. Genital ulcers associated with human immunodeficiency virus-related immunosuppression in female sex workers in Abidjan, Ivory Coast. J Infect Dis. 1995 Nov;172(5):1371–1374. doi: 10.1093/infdis/172.5.1371. [DOI] [PubMed] [Google Scholar]
  16. Grady W. R., Tanfer K. Condom breakage and slippage among men in the United States. Fam Plann Perspect. 1994 May-Jun;26(3):107–112. [PubMed] [Google Scholar]
  17. Grosskurth H., Mosha F., Todd J., Mwijarubi E., Klokke A., Senkoro K., Mayaud P., Changalucha J., Nicoll A., ka-Gina G. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet. 1995 Aug 26;346(8974):530–536. doi: 10.1016/s0140-6736(95)91380-7. [DOI] [PubMed] [Google Scholar]
  18. Hardy P. H., Hardy J. B., Nell E. E., Graham D. A., Spence M. R., Rosenbaum R. C. Prevalence of six sexually transmitted disease agents among pregnant inner-city adolescents and pregnancy outcome. Lancet. 1984 Aug 11;2(8398):333–337. doi: 10.1016/s0140-6736(84)92698-9. [DOI] [PubMed] [Google Scholar]
  19. Hobbs M. M., Kazembe P., Reed A. W., Miller W. C., Nkata E., Zimba D., Daly C. C., Chakraborty H., Cohen M. S., Hoffman I. Trichomonas vaginalis as a cause of urethritis in Malawian men. Sex Transm Dis. 1999 Aug;26(7):381–387. doi: 10.1097/00007435-199908000-00003. [DOI] [PubMed] [Google Scholar]
  20. Ipsen J., Feigl P. A biomathematical model for prevalence of Trichomonas vaginalis. Am J Epidemiol. 1970 Feb;91(2):175–184. doi: 10.1093/oxfordjournals.aje.a121126. [DOI] [PubMed] [Google Scholar]
  21. Joyner J. L., Douglas J. M., Jr, Ragsdale S., Foster M., Judson F. N. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic. Sex Transm Dis. 2000 Apr;27(4):236–240. doi: 10.1097/00007435-200004000-00010. [DOI] [PubMed] [Google Scholar]
  22. Kiviat N. B., Paavonen J. A., Brockway J., Critchlow C. W., Brunham R. C., Stevens C. E., Stamm W. E., Kuo C. C., DeRouen T., Holmes K. K. Cytologic manifestations of cervical and vaginal infections. I. Epithelial and inflammatory cellular changes. JAMA. 1985 Feb 15;253(7):989–996. [PubMed] [Google Scholar]
  23. Kreiss J., Willerford D. M., Hensel M., Emonyi W., Plummer F., Ndinya-Achola J., Roberts P. L., Hoskyn J., Hillier S., Kiviat N. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J Infect Dis. 1994 Dec;170(6):1597–1601. doi: 10.1093/infdis/170.6.1597. [DOI] [PubMed] [Google Scholar]
  24. Krieger J. N., Verdon M., Siegel N., Critchlow C., Holmes K. K. Risk assessment and laboratory diagnosis of trichomoniasis in men. J Infect Dis. 1992 Dec;166(6):1362–1366. doi: 10.1093/infdis/166.6.1362. [DOI] [PubMed] [Google Scholar]
  25. Laga M., Manoka A., Kivuvu M., Malele B., Tuliza M., Nzila N., Goeman J., Behets F., Batter V., Alary M. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993 Jan;7(1):95–102. doi: 10.1097/00002030-199301000-00015. [DOI] [PubMed] [Google Scholar]
  26. Levine W. C., Pope V., Bhoomkar A., Tambe P., Lewis J. S., Zaidi A. A., Farshy C. E., Mitchell S., Talkington D. F. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis. 1998 Jan;177(1):167–174. doi: 10.1086/513820. [DOI] [PubMed] [Google Scholar]
  27. Madico G., Quinn T. C., Rompalo A., McKee K. T., Jr, Gaydos C. A. Diagnosis of Trichomonas vaginalis infection by PCR using vaginal swab samples. J Clin Microbiol. 1998 Nov;36(11):3205–3210. doi: 10.1128/jcm.36.11.3205-3210.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mayta H., Gilman R. H., Calderon M. M., Gottlieb A., Soto G., Tuero I., Sanchez S., Vivar A. 18S ribosomal DNA-based PCR for diagnosis of Trichomonas vaginalis. J Clin Microbiol. 2000 Jul;38(7):2683–2687. doi: 10.1128/jcm.38.7.2683-2687.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. McCormack W. M., Evrard J. R., Laughlin C. F., Rosner B., Alpert S., Crockett V. A., McComb D., Zinner S. H. Sexually transmitted conditions among women college students. Am J Obstet Gynecol. 1981 Jan 15;139(2):130–133. doi: 10.1016/0002-9378(81)90433-6. [DOI] [PubMed] [Google Scholar]
  30. Miller J. M., Chambers D. C., Miller J. M. Infection with Trichomonas vaginalis in a black population. J Natl Med Assoc. 1989 Jun;81(6):701–702. [PMC free article] [PubMed] [Google Scholar]
  31. Niccolai L. M., Kopicko J. J., Kassie A., Petros H., Clark R. A., Kissinger P. Incidence and predictors of reinfection with Trichomonas vaginalis in HIV-infected women. Sex Transm Dis. 2000 May;27(5):284–288. doi: 10.1097/00007435-200005000-00009. [DOI] [PubMed] [Google Scholar]
  32. Osborne N. G., Grubin L., Pratson L. Vaginitis in sexually active women: relationship to nine sexually transmitted organisms. Am J Obstet Gynecol. 1982 Apr 15;142(8):962–967. doi: 10.1016/0002-9378(82)90775-x. [DOI] [PubMed] [Google Scholar]
  33. Pabst K. M., Reichart C. A., Knud-Hansen C. R., Wasserheit J. N., Quinn T. C., Shah K., Dallabetta G., Hook E. W., 3rd Disease prevalence among women attending a sexually transmitted disease clinic varies with reason for visit. Sex Transm Dis. 1992 Mar-Apr;19(2):88–91. [PubMed] [Google Scholar]
  34. Ris H. W., Dodge R. W. Trichomonas and yeast vaginitis in institutionalized adolescent girls. Am J Dis Child. 1973 Feb;125(2):206–209. doi: 10.1001/archpedi.1973.04160020038007. [DOI] [PubMed] [Google Scholar]
  35. Rosenberg M. J., Davidson A. J., Chen J. H., Judson F. N., Douglas J. M. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health. 1992 May;82(5):669–674. doi: 10.2105/ajph.82.5.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sardana S., Sodhani P., Agarwal S. S., Sehgal A., Roy M., Singh V., Bhatnagar P., Murthy N. S. Epidemiologic analysis of Trichomonas vaginalis infection in inflammatory smears. Acta Cytol. 1994 Sep-Oct;38(5):693–697. [PubMed] [Google Scholar]
  37. Saxena S. B., Jenkins R. R. Prevalence of Trichomonas vaginalis in men at high risk for sexually transmitted diseases. Sex Transm Dis. 1991 Jul-Sep;18(3):138–142. doi: 10.1097/00007435-199107000-00002. [DOI] [PubMed] [Google Scholar]
  38. Scholes D., Stergachis A., Ichikawa L. E., Heidrich F. E., Holmes K. K., Stamm W. E. Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol. 1998 Jun;91(6):993–997. doi: 10.1016/s0029-7844(98)00095-7. [DOI] [PubMed] [Google Scholar]
  39. Schwebke J. R., Morgan S. C., Pinson G. B. Validity of self-obtained vaginal specimens for diagnosis of trichomoniasis. J Clin Microbiol. 1997 Jun;35(6):1618–1619. doi: 10.1128/jcm.35.6.1618-1619.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Shafer M. A., Sweet R. L., Ohm-Smith M. J., Shalwitz J., Beck A., Schachter J. Microbiology of the lower genital tract in postmenarchal adolescent girls: differences by sexual activity, contraception, and presence of nonspecific vaginitis. J Pediatr. 1985 Dec;107(6):974–981. doi: 10.1016/s0022-3476(85)80208-0. [DOI] [PubMed] [Google Scholar]
  41. Shuter J., Bell D., Graham D., Holbrook K. A., Bellin E. Y. Rates of and risk factors for trichomoniasis among pregnant inmates in New York City. Sex Transm Dis. 1998 Jul;25(6):303–307. doi: 10.1097/00007435-199807000-00006. [DOI] [PubMed] [Google Scholar]
  42. Sorvillo F., Kovacs A., Kerndt P., Stek A., Muderspach L., Sanchez-Keeland L. Risk factors for trichomoniasis among women with human immunodeficiency virus (HIV) infection at a public clinic in Los Angeles County, California: implications for HIV prevention. Am J Trop Med Hyg. 1998 Apr;58(4):495–500. doi: 10.4269/ajtmh.1998.58.495. [DOI] [PubMed] [Google Scholar]
  43. Stewart D. L., DeForge B. R., Hartmann P., Kaminski M., Pecukonis E. Attitudes toward condom use and AIDS among patients from an urban family practice center. J Natl Med Assoc. 1991 Sep;83(9):772–776. [PMC free article] [PubMed] [Google Scholar]
  44. Wiese W., Patel S. R., Patel S. C., Ohl C. A., Estrada C. A. A meta-analysis of the Papanicolaou smear and wet mount for the diagnosis of vaginal trichomoniasis. Am J Med. 2000 Mar;108(4):301–308. doi: 10.1016/s0002-9343(99)00466-0. [DOI] [PubMed] [Google Scholar]
  45. Wilkinson D., Abdool Karim S. S., Harrison A., Lurie M., Colvin M., Connolly C., Sturm A. W. Unrecognized sexually transmitted infections in rural South African women: a hidden epidemic. Bull World Health Organ. 1999;77(1):22–28. [PMC free article] [PubMed] [Google Scholar]
  46. Wilson T. E., Minkoff H., DeHovitz J., Feldman J., Landesman S. The relationship of cocaine use and human immunodeficiency virus serostatus to incident sexually transmitted diseases among women. Sex Transm Dis. 1998 Feb;25(2):70–75. doi: 10.1097/00007435-199802000-00003. [DOI] [PubMed] [Google Scholar]
  47. Wilson T. E., Minkoff H., McCalla S., Petterkin C., Jaccard J. The relationship between pregnancy and sexual risk taking. Am J Obstet Gynecol. 1996 Mar;174(3):1033–1036. doi: 10.1016/s0002-9378(96)70346-0. [DOI] [PubMed] [Google Scholar]
  48. Wølner-Hanssen P., Krieger J. N., Stevens C. E., Kiviat N. B., Koutsky L., Critchlow C., DeRouen T., Hillier S., Holmes K. K. Clinical manifestations of vaginal trichomoniasis. JAMA. 1989 Jan 27;261(4):571–576. doi: 10.1001/jama.1989.03420040109029. [DOI] [PubMed] [Google Scholar]
  49. ter Meulen J., Mgaya H. N., Chang-Claude J., Luande J., Mtiro H., Mhina M., Kashaija P., Pawlita M. Risk factors for HIV infection in gynaecological inpatients in Dar es Salaam, Tanzania, 1988-1990. East Afr Med J. 1992 Dec;69(12):688–692. [PubMed] [Google Scholar]
  50. van Der Schee C., van Belkum A., Zwijgers L., van Der Brugge E., O'neill E. L., Luijendijk A., van Rijsoort-Vos T., van Der Meijden W. I., Verbrugh H., Sluiters H. J. Improved diagnosis of Trichomonas vaginalis infection by PCR using vaginal swabs and urine specimens compared to diagnosis by wet mount microscopy, culture, and fluorescent staining. J Clin Microbiol. 1999 Dec;37(12):4127–4130. doi: 10.1128/jcm.37.12.4127-4130.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES